These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22825572)

  • 1. The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
    Liu P; Gou M; Yi T; Qi X; Xie C; Zhou S; Deng H; Wei Y; Zhao X
    Int J Oncol; 2012 Oct; 41(4):1504-12. PubMed ID: 22825572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
    Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
    Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
    Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
    Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.
    Bai Y; Gou M; Yi T; Yang L; Liu L; Lin X; Su D; Wei Y; Zhao X
    Int J Med Sci; 2015; 12(5):397-406. PubMed ID: 26005374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.
    Liu L; Gou M; Yi T; Bai Y; Wei Y; Zhao X
    Oncol Rep; 2014 Apr; 31(4):1623-8. PubMed ID: 24482188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
    Xie C; Gou ML; Yi T; Deng H; Li ZY; Liu P; Qi XR; He X; Wei Y; Zhao X
    Hum Gene Ther; 2011 Nov; 22(11):1413-22. PubMed ID: 21513424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor effect of biodegradable cationic heparin-polyethyleneimine nanogels delivering FILIP1LΔC103 gene combined with low-dose cisplatin on ovarian cancer.
    Xie C; Gou M; Yi T; Qi X; Liu P; Wei Y; Zhao X
    Oncotarget; 2017 Sep; 8(44):76432-76442. PubMed ID: 29100323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo.
    Wei W; Mu Y; Li X; Gou M; Zhang H; Luo S; Men K; Mao Y; Qian Z; Yang L
    J Biomed Nanotechnol; 2011 Dec; 7(6):768-75. PubMed ID: 22416575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of PLGA nanoparticles encapsulating the human PNAS-4 gene combined with cisplatin in ovarian cancer.
    Qi X; Song X; Liu P; Yi T; Li S; Xie C; Zheng Y; Bai Y; Sun C; Wei Y; Zhao X
    Oncol Rep; 2011 Sep; 26(3):703-10. PubMed ID: 21667029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine.
    Gou M; Men K; Zhang J; Li Y; Song J; Luo S; Shi H; Wen Y; Guo G; Huang M; Zhao X; Qian Z; Wei Y
    ACS Nano; 2010 Oct; 4(10):5573-84. PubMed ID: 20839784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma.
    Liu Y; Chen L; He X; Fan L; Yang G; Chen X; Lin X; DU L; Li Z; Ye H; Mao Y; Zhao X; Wei Y
    Int J Gynecol Cancer; 2008; 18(4):652-9. PubMed ID: 17892458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
    Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
    Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model.
    Mabuchi S; Terai Y; Morishige K; Tanabe-Kimura A; Sasaki H; Kanemura M; Tsunetoh S; Tanaka Y; Sakata M; Burger RA; Kimura T; Ohmichi M
    Clin Cancer Res; 2008 Dec; 14(23):7781-9. PubMed ID: 19047105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enhancement of antitumor effect of cisplatin on human ovarian cancer by cyclosporin A in vitro and in vivo].
    Zhou Y; Chen H; Yang Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):25-8. PubMed ID: 8758815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.
    Staub J; Chien J; Pan Y; Qian X; Narita K; Aletti G; Scheerer M; Roberts LR; Molina J; Shridhar V
    Oncogene; 2007 Jul; 26(34):4969-78. PubMed ID: 17310998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.
    Luo L; Du T; Zhang J; Zhao W; Cheng H; Yang Y; Wu Y; Wang C; Men K; Gou M
    Int J Nanomedicine; 2016; 11():501-12. PubMed ID: 26893558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.
    Zhang L; Gao X; Men K; Wang B; Zhang S; Qiu J; Huang M; Gou M; Huang N; Qian Z; Zhao X; Wei Y
    Int J Nanomedicine; 2011; 6():2419-27. PubMed ID: 22072877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.